Skip to Main Navigation Skip to Main Content Skip to Footer
search play2 play3 facebook twitter linkedin2 cross instagram
ASCP
  • DASHBOARD
  • STORE
  • LOGOUT
  • STORE
  • LOGIN
Menu
  • Jobs
  • ASCP
  • User Auth Test Page
  • FDA Authorizes COVID-19 Home Test From ACON Laboratories

    USA Today (10/4, Alltucker) reports that on Monday, the FDA “authorized a new coronavirus home test that the agency says will soon double the nation’s limited supply of non-prescription tests.” The “emergency use authorization of ACON Laboratories Flowfle...
    Full Article
  • Study Involving Cells And Mice Indicates Myc Gene May Make Oligodendrocyte Precursor Cells More Efficient

    Multiple Sclerosis News Today (10/4, Wexler) reports, “Increasing the activity of a gene called Myc can make oligodendrocyte precursor cells, or the cells that repair myelin, more efficient – ‘ground-breaking research’ that could have implications for adv...
    Full Article
  • Topline Results Of Phase 3 Study Indicate Benefit From Prevnar 20 Administered With Seasonal Influenza Vaccine

    Infectious Disease Advisor (10/4, Park) reports, “Positive topline results were announced from a phase 3 study evaluating the safety and immunogenicity of Prevnar 20 (pneumococcal 20-valent conjugate vaccine) administered with the seasonal influenza vacci...
    Full Article
  • Study Suggests Short-Course Antimicrobial Therapy May Be As Effective As Prolonged-Course Therapy For Patients With BSI Caused By Pseudomonas Aeruginosa

    Infectious Disease Advisor (10/4, Purdy) reports on research finding that “short-course antimicrobial therapy may be as effective as prolonged-course therapy for the treatment of patients with uncomplicated bloodstream infections (BSI) caused by Pseudomon...
    Full Article
  • Women with uUTI And Antimicrobial-Resistant Isolates At Increased Risk For cUTI Compared To Women With Susceptible Isolates

    Infectious Disease Advisor (10/4) reports on research finding that “women with uncomplicated urinary tract infection (uUTI) and antimicrobial-resistant isolates were found to be at significantly increased risk for progression to complicated UTI (cUTI) com...
    Full Article
  • Standardized, Microbiota-Based Investigational Live Biotherapeutic May Decrease Risk Of rCDI, Study Finds

    Infectious Disease Advisor (10/4) reports on research finding that “a standardized, microbiota-based investigational live biotherapeutic, RBX2660, was found to consistently decrease the risk for recurrent Clostridioides difficile infections (rCDI).” The r...
    Full Article
  • Study Identifies Ways To Find Potential Biomarkers Associated With COVID-19 Disease Severity Among Children With SARS-CoV-2 Infection

    Infectious Disease Advisor (10/4, Cimino) reports on research finding that “among children with SARS-CoV-2 infection, assessing differences in immunity profiles and correlations between serum cytokine measurements and certain clinical parameters may help...
    Full Article
  • Young Men At Three Times The Risk Of Myocarditis Following Second Shot Of Pfizer-BioNTech, Moderna COVID-19 Vaccines Compared To First Dose, Study Finds

    The New York Times (10/4, Mandavilli) reports on research finding “a second dose of the coronavirus vaccines made by Pfizer-BioNTech and Moderna can nearly triple the chances of a rare heart condition in young men,” but “the absolute risk of the condition...
    Full Article
  • COVID-19 Prevention Treatment Safe, Shows Efficacy In High-Risk Groups, Presentation Indicates

    MedPage Today (10/3, Walker) reports, “A monoclonal antibody cocktail designed for COVID-19 pre-exposure prophylaxis was safe, and appeared to be effective across populations at risk of severe COVID and who may have a subpar response to vaccination, a res...
    Full Article
  • Study Examines Relative Effectiveness Of Egg- Vs Cell-Based Quadrivalent Influenza Vaccines In Periods Of Increased Influenza Activity

    Infectious Disease Advisor (10/2, Nye) reported, “During either a period of increased influenza activity or a general influenza season, a retrospective cohort study found that a quadrivalent cell-based influenza vaccine (QIVc) was associated with a greate...
    Full Article
  • Research Finds Link Between Antimicrobial-Resistant Pathogens And Seasonal Influenza Infection Rates

    Infectious Disease Advisor (10/2, Nye) reported, “A surprising association was found between antimicrobial-resistant Gram-negative (GN) pathogens and seasonal influenza epidemic patterns, as well as evidence for a correlation between Gram-positive (GP) pa...
    Full Article
  • Study Finds Single-Dose Lysin Shows Promise Against S. Aureus

    Healio (10/2, Downey) reported, “Patients with Staphylococcus aureus who were treated with exebacase, a recombinantly produced lysin, achieved symptom resolution in half the time compared with participants who received placebo, researchers reported at IDW...
    Full Article
  • Studies Suggest COVID-19 Is Evolving To Spread More Efficiently Through Air

    The New York Times (10/1, Mandavilli) reported, “Newer variants of the coronavirus like Alpha and Delta are highly contagious, infecting far more people than the original virus.” Two recent studies suggest why: “The virus is evolving to spread more effici...
    Full Article
  • People With HIV Have Less Robust Response To COVID-19 Vaccines, Study Suggests

    Healio (10/2, Downey) reports, “People with HIV have a less robust response to COVID-19 vaccination than those without HIV, data presented at IDWeek suggest.” Researchers “matched 100 people with HIV with 100 adult patients without HIV who were receiving...
    Full Article
  • Trial Studies Outcomes Of Rapid Treatment With Sofosbuvir-Velpatasvir In Patients With Hepatitis C Virus Who Use Injectable Drugs

    Infectious Disease Advisor (10/2, Heck) reported, “Among patients with hepatitis C virus (HCV) infection with a history of injectable drug use, those who underwent rapid treatment with a 7-day course of sofosbuvir-velpatasvir achieved significantly increa...
    Full Article
  • Study Finds IDC Increased Treatment Adherence Among Patients With Enterococcus Species

    Infectious Disease Advisor (10/2, Heck) reported, “In patients infected with Enterococcus species, there were no differences observed in regard to composite failure rates among those who did or did not undergo an infectious disease consultation (IDC).” Ho...
    Full Article
  • Analysis Finds Association Between Tenofovir Disoproxil Fumarate And Weight Loss In Individuals Who Test Negative For HIV Infection

    Infectious Disease Advisor (10/2, Heck) reported, “Compared with placebo, treatment with tenofovir disoproxil fumarate (TDF) was associated with a significantly increased likelihood for weight loss in patients who were negative for HIV infection, accordin...
    Full Article
  • Experts Urge Americans To Get Vaccinated For Both COVID-19, Flu

    The AP (9/30, Neergaard) reports, “Amid all the focus on COVID-19 vaccinations, U.S. health experts have another plea: Don’t skip your flu shot.” Though “flu cases have dropped to historically low levels during the pandemic,” reopening of businesses, retu...
    Full Article
  • Results Of At-Home COVID-19 Tests Vary, Accuracy Contingent On Tests Being Used Correctly

    The New York Times (9/29, Anthes) reports, “Demand for [coronavirus] tests has surged in recent months, as the highly infectious Delta variant has spread and schools and offices have reopened.” Though “rapid tests have their limitations, they are an impor...
    Full Article
  • AstraZeneca Says Its COVID-19 Vaccine Was 74% Effective In Large US Trial

    The Hill (9/30, Scully) reports, “British drugmaker AstraZeneca’s COVID-19 vaccine Vaxzevria has been found to have a 74 percent efficacy in preventing symptomatic disease, according to a report published Wednesday in the New England Journal of Medicine.”...
    Full Article
  • «
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • »
Footer
Chicago (Headquarters)
33 West Monroe Street, Suite 1600, Chicago, IL 60603

Privacy Policy 

Terms of Use

Follow Us

Copyright ©2021  by American Society for Clinical Pathology. All Rights Reserved.

Chat With BOC

close
First Name *
Last Name *
Email *
Customer ID

Request a Call from Customer Relations

Close
Name *
Topic *
Phone Number *
Scheduled Date *
Scheduled Time *
Customer Id